We next analyzed phospho-proteins that are related to downstream signaling of ERBB2 and found increased phosphorylation of MAP2K2, RAF1, SHC1, GAB2, or EIF4B associated with MAP Kinase and AKT activity in metastatic SCLC (Supplementary Fig. 3b). Here, ERBB2 is linked to small cell lung carcinoma.